Ectopic Expression of Necdin Induces Differentiation of Mouse Neuroblastoma Cells*

  1. Kazuaki Yoshikawa
  1. From the Division of Regulation of Macromolecular Functions, Institute for Protein Research, Osaka University, Yamadaoka 3-2, Suita, Osaka 565-0871, Japan

Abstract

Necdin is expressed predominantly in postmitotic neurons, and ectopic expression of this protein strongly suppresses cell growth. Necdin has been implicated in the pathogenesis of Prader-Willi syndrome, a human neurodevelopmental disorder associated with genomic imprinting. Here we demonstrate that ectopic expression of necdin induces a neuronal phenotype in neuroblastoma cells. Necdin was undetectable in mouse neuroblastoma N1E-115 cells under undifferentiated and differentiated conditions. N1E-115 cells transfected with necdin cDNA showed morphological differentiation such as neurite outgrowth and expression of the synaptic marker proteins synaptotagmin and synaptophysin. In addition, Western blot analysis of the retinoblastoma protein (Rb) family members Rb, p130, and p107 revealed that necdin cDNA transfectants contained an increased level of p130 and a reduced level of p107, a pattern seen in differentiated G0 cells. The transcription factors E2F1 and E2F4 physically interacted with necdin via their carboxyl-terminal transactivation domains, but only E2F1 abrogated necdin-induced growth arrest and neurite outgrowth of neuroblastoma cells. Overexpression of E2F1 in differentiated N1E-115 cells induced apoptosis, which was antagonized by co-expression of necdin. These results suggest that necdin promotes the differentiation and survival of neurons through its antagonistic interactions with E2F1.

  • Abbreviations:
    PWS
    Prader-Willi syndrome
    Rb
    retinoblastoma protein
    BrdUrd
    bromodeoxyuridine
    TUNEL
    terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick-end labeling
    MBP
    maltose-binding protein
    FBS
    fetal bovine serum
    PBS
    phosphate-buffered saline
    FITC
    fluorescein isothiocyanate
    • Received May 22, 2002.
    • Revision received August 9, 2002.
    Table of Contents

    Submit your work to JBC.

    You'll be in good company.